基因组不稳定性衍生 lncRNAs预后特征和相关瘤微环境的综合分析
Yanyi Peng1, Lingyue Zhang1, Mengqi Zhang1,2
1Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.
概括
在质瘤中发现了与基因组不稳定性相关的长非编码RNA (lncRNA). 开发了一个16基因预后模型 (GILncSig) 来预测患者的结果并指导个性化治疗策略.
科学领域:
- 癌症学
- 基因组学
- 生物信息学
背景情况:
- 基因组不稳定是癌症的一个关键特征.
- 长非编码RNAs (lncRNAs) 在癌症发展中起作用.
- 质瘤是一种具有复杂基因组变异的重大脑瘤.
研究的目的:
- 在质瘤中识别基因组不稳定相关的 lncRNAs (GILnc).
- 开发基于GILnc的质瘤患者的预后模型.
- 探索基因组不稳定的质瘤的潜在治疗点和药物.
主要方法:
- 用于GILnc识别的计算框架.
- 免疫评分和免疫细胞透分析 (ESTIMATE,CIBERSORT).
- 预后建模 (Cox回归),ceRNA网络构建,药物预测 (Cmap,STITCH).
主要成果:
- 确定了一组与质瘤预后显著相关的GILnc.
- 开发了一个16基因预后模型 (GILncSig) 来进行风险评估.
- 编制了整合临床参数的诺姆图,并预测了潜在的抗瘤药物.
结论:
- GILncSig模型为质瘤提供了强大的独立预测能力.
- 这些发现提供了关于质瘤中的GILnc和潜在的治疗干预措施的见解.
- 这项研究支持针对基因组不稳定的质瘤患者的个性化治疗策略.
相关概念视频
lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K


